Watch MLYS. Know when insiders buy.
One email the day a filing lands. Free.
MLYS
Mineralys Therapeutics, Inc.
21.10
−0.48 −2.22%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
42
WATCH · insiders 25, shorts 58
Insiders, 90 days
−$5.4M
net selling · 0 buys, 5 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.9BP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$349.6MNET CASH $138.2M52W 20.30 – 47.33NEXT EARNINGS Nov 10 EST.SEC XBRL · TTM TO Invalid Date
Insider trading
−$5.4M
Net, 90 days
0 / 5
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 30 | Oct 2 | Congleton Jon · Chief Executive Officer | Sell | 75,000 | $25.46 | $1.9M |
| Sep 22 | Sep 24 | Slingsby Brian Taylor · Director | Sell | 104,320 | $28.81 | $3M |
| Sep 21 | Sep 22 | Warren Eric · Chief Commercial Officer | Sell | 7,438 | $28.12 | $209K |
| Sep 15 | Sep 17 | Karydas Daphne · Director | Sell | 3,000 | $28.58 | $86K |
| Aug 21 | Aug 25 | Warren Eric · Chief Commercial Officer | Sell | 7,437 | $25.98 | $193K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.